Table of Contents
Chapter 1. Global Blood Glucose Monitoring Devices Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer's Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
Chapter 2. Executive Summary
2.1. Global Blood Glucose Monitoring Devices Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Product
2.3.2. By End-use
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Global Blood Glucose Monitoring Devices Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Global Blood Glucose Monitoring Devices Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Blood Glucose Monitoring Devices Market Size & Forecasts by Product 2022-2032
5.1. Self-monitoring Devices
5.2. Continuous Blood Glucose Monitoring Devices
Chapter 6. Global Blood Glucose Monitoring Devices Market Size & Forecasts by End-use 2022-2032
6.1. Hospitals
6.2. Home Care
6.3. Diagnostic Centers
Chapter 7. Global Blood Glucose Monitoring Devices Market Size & Forecasts by Region 2022-2032
7.1. North America Blood Glucose Monitoring Devices Market
7.1.1. U.S. Blood Glucose Monitoring Devices Market
7.1.1.1. Product breakdown size & forecasts, 2022-2032
7.1.1.2. End-use breakdown size & forecasts, 2022-2032
7.1.2. Canada Blood Glucose Monitoring Devices Market
7.2. Europe Blood Glucose Monitoring Devices Market
7.2.1. U.K. Blood Glucose Monitoring Devices Market
7.2.2. Germany Blood Glucose Monitoring Devices Market
7.2.3. France Blood Glucose Monitoring Devices Market
7.2.4. Spain Blood Glucose Monitoring Devices Market
7.2.5. Italy Blood Glucose Monitoring Devices Market
7.2.6. Rest of Europe Blood Glucose Monitoring Devices Market
7.3. Asia-Pacific Blood Glucose Monitoring Devices Market
7.3.1. China Blood Glucose Monitoring Devices Market
7.3.2. India Blood Glucose Monitoring Devices Market
7.3.3. Japan Blood Glucose Monitoring Devices Market
7.3.4. Australia Blood Glucose Monitoring Devices Market
7.3.5. South Korea Blood Glucose Monitoring Devices Market
7.3.6. Rest of Asia Pacific Blood Glucose Monitoring Devices Market
7.4. Latin America Blood Glucose Monitoring Devices Market
7.4.1. Brazil Blood Glucose Monitoring Devices Market
7.4.2. Mexico Blood Glucose Monitoring Devices Market
7.4.3. Rest of Latin America Blood Glucose Monitoring Devices Market
7.5. Middle East & Africa Blood Glucose Monitoring Devices Market
7.5.1. Saudi Arabia Blood Glucose Monitoring Devices Market
7.5.2. South Africa Blood Glucose Monitoring Devices Market
7.5.3. Rest of Middle East & Africa Blood Glucose Monitoring Devices Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Thermo Fisher Scientific, Inc.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Abbott Laboratories
8.3.3. Medtronic plc
8.3.4. F. Hoffmann-La Roche Ltd
8.3.5. Ascensia Diabetes Care Holdings AG
8.3.6. Dexcom, Inc.
8.3.7. Novo Nordisk A/S
8.3.8. Insulet Corporation
8.3.9. Ypsomed AG
8.3.10. Glysens Incorporated
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes